ANG-PA:NYE-American National Group Inc. (USD)

COMMON STOCK | Insurance - Life |

Last Closing

USD 25.48

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
AFL Aflac Incorporated

-2.12 (-2.03%)

USD 59.65B
MET-PA MetLife Inc Preferred Stock Se..

+0.06 (+0.24%)

USD 48.93B
MET-PE MetLife Inc Preferred Stock Se..

-0.02 (-0.08%)

USD 43.29B
PRU Prudential Financial Inc

-1.63 (-1.47%)

USD 39.68B
PUK Prudential PLC ADR

-0.18 (-0.99%)

USD 24.05B
PRI Primerica Inc

-6.52 (-2.33%)

USD 9.48B
JXN Jackson Financial Inc

-3.69 (-4.32%)

USD 6.89B
FG F&G Annuities & Life Inc.

-3.84 (-8.72%)

USD 5.66B
ANG-PB American National Group Inc

-0.02 (-0.08%)

N/A
MET-PF MetLife Inc Preferred Stock Se..

+0.06 (+0.29%)

N/A

ETFs Containing ANG-PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.11% 40% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.11% 25% F 38% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.